Youqiang Ke
Overview
Explore the profile of Youqiang Ke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He G, Zhang Y, Feng Y, Chen T, Liu M, Zeng Y, et al.
J Cell Mol Med
. 2024 Mar;
28(7):e18212.
PMID: 38516826
SBFI26, an inhibitor of FABP5, has been shown to suppress the proliferation and metastasis of tumour cells. However, the underlying mechanism by which SBFI26 induces ferroptosis in breast cancer cells...
2.
Abdulsamad S, Naeem A, Zeng H, He G, Jin X, Alenezi B, et al.
Am J Cancer Res
. 2024 Feb;
14(1):300-323.
PMID: 38323289
Enzalutamide is a drug used to treat prostate cancer (PC) and docetaxel is a drug for chemotherapeutic treatment of diverse cancer types, including PC. The effectiveness of these drugs in...
3.
Naeem A, Abdulsamad S, Zeng H, He G, Jin X, Zhang J, et al.
Int J Oncol
. 2023 Dec;
64(2).
PMID: 38131188
Fatty acid‑binding protein 5 (FABP5) and androgen receptor (AR) are critical promoters of prostate cancer. In the present study, the effects of knocking out the or genes on malignant characteristics...
4.
Zhang J, He G, Jin X, Alenezi B, Naeem A, Abdulsamad S, et al.
Cell Biol Int
. 2023 Jan;
47(5):929-942.
PMID: 36651331
Previous work showed that FABP5 inhibitors suppressed the malignant progression of prostate cancer cells, and this suppression might be achieved partially by promoting apoptosis. But the mechanisms involved were not...
5.
Ke Y
J Interferon Cytokine Res
. 2022 Sep;
42(11):592-593.
PMID: 36112111
Recently, messenger ribonucleic acid (mRNA) vaccine research and development became a hotspot in the field of prevention and treatment of Corona Virus Disease 2019 (COVID-19) and some other disorders. mRNA...
6.
Naeem A, Abdulsamad S, Rudland P, Malki M, Ke Y
Precis Clin Med
. 2022 Jun;
2(3):192-196.
PMID: 35694437
In this short communication, a novel fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in prostate cancer is reviewed. In castration-resistant prostate cancer (CRPC) cells, the FABP5-related signal transduction pathway...
7.
Al-Jameel W, Gou X, Forootan S, Al Fayi M, Rudland P, Forootan F, et al.
Oncotarget
. 2020 Aug;
11(31):3025.
PMID: 32821347
[This corrects the article DOI: 10.18632/oncotarget.16055.].
8.
Al-Jameel W, Gou X, Jin X, Zhang J, Wei Q, Ai J, et al.
Genes Cancer
. 2019 Jul;
10(3-4):80-96.
PMID: 31258834
Previous study has suggested that the FABP5-PPARγ-signalling transduction pathway gradually replaces the androgen receptor activated pathway in promoting malignant progression of castration-resistant prostate cancer (CRPC) cells. To interfere with this...
9.
Al-Jameel W, Gou X, Forootan S, Al Fayi M, Rudland P, Forootan F, et al.
Oncotarget
. 2017 Apr;
8(19):31041-31056.
PMID: 28415688
Castration resistant-prostate cancer is largely impervious to feather hormonal therapy and hence the outlook for patients is grim. Here we use an approach to attach the recently discovered Achilles heel....
10.
Al Fayi M, Gou X, Forootan S, Al-Jameel W, Bao Z, Rudland P, et al.
Oncotarget
. 2016 Oct;
7(50):82783-82797.
PMID: 27779102
In contrast to numerous studies conducted to investigate the crucial role of fatty acid binding protein 5 (FABP5) in prostate cancer, investigations on the possible involvement of other FABPs are...